Fall 2009 Symposium

The Role of Ceramide, Sphingomyelinases and Sphingosine 1 Phosphate Signaling in Pulmonary Diseases

Friday, October 30th 2009

Charles River Shrewsbury Facility

Shrewsbury, MA 01545

Organizers:
Lawrence de Garavilla , Ph.D.
Carolyn Cuff , Ph.D.
Lisa Olson, Ph.D.
Scientific advisor: Dr. Richard N. Kolesnick, Sloan-Kettering Institute

MEETING ANNOUNCEMENT (PDF file)

Click Here For Online Registration Registration is Mandatory for Attendance

Presentations:

Richard Kolesnick - Memorial Sloan-Kettering

· Signal Transduction through Lipid Messengers: Classical Diacylglycerol Pathway vs the Newer Ceramide Sphingomyelin Pathway.

Irina Petrache - Indiana University

· Injurious Effects of Ceramide Elevations in Models of COPD

Daniela Salvemini - St. Louis University School of Medicine

· Role of Ceramide in the Development of Airway Hyperreactivity

Robert Bittman - Queens College

· Ceramide Synthesis is Modulated by the Sphingosine Analog FTY720

Erich Gulbins - University of Duisburg-Essen

· Anti-sphingomyelinase in the Treatment Cystic Fibrosis: Preclinical and Clinical Experiences

Bob Stoffel - Abbott Laboratories

· Introduction to S1P Receptor Biology.

Steven Dudek - University of Chicago

· S1P Receptors in Inflammatory Lung Injury.

Marco Idzko - Institution, University Hospital Freiburg Germany

· Regulation of Immune Function by FTY720 in Asthma.

Return to PRG Home Page







© Jon Phillips 2009